Our articles usually cover pain, injury and movement. Every so often we share a general research roundup, and this one concerns gut health.
In an August 2026 newsletter for practitioners, Metagenics featured Akkermansia muciniphila MucT. Akkermansia is a natural resident of the human gut. MucT is a specific strain, used by Metagenics in a heat-treated form that the company calls a postbiotic.
Researchers led by Mount published a randomised controlled trial in Nature Medicine in 2026. The 84 participants were adults with overweight or obesity. Following an eight-week weight-loss phase, half took MucT and half took a placebo daily for 24 weeks, and the study compared weight regain between the groups.
Body weight is one of many factors people discuss with us when joints or backs are sore. That makes it tempting to look for a simple add-on. We would rather be clear: a supplement is never a substitute for a proper assessment, a movement plan and input from your GP. Metagenics includes MucT in its UltraFlora Weight & Metabolic Health with Akkermansia product; we name it only so you know what it is.
To discuss your own plan, ask at your next consultation or book on 0410 699 065.
Copyright© 2002-2026 visuallink© SaaS - Web Hosted Solutions, Design and Maintenance by Visual Link IT Pty Ltd - Software Solutions
评论已关闭